eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2012
vol. 44
 
Share:
Share:
abstract:
Original article

The influence of low flow anaesthesia on renal function in cancer patients previously treated with nephrotoxic chemotherapeutic agents

Online publish date: 2019/09/12
View full text Get citation
 
Background
The aim of this study was to assess renal morbidity, associated with the use of low flow anaesthesia (LFA), in cancer patients previously treated with nephrotoxic chemotherapeutic agents.

Methods
Seventy-five patients, aged 30–70 years, scheduled for elective surgery, were randomly allocated to three groups: Group A included those patients who had received nephrotoxic chemotherapeutic agents (cisplatin, carboplatin, methotrexate or cyclophosphamide) within 90 days before surgery, and who were anaesthetised with low flow (0.8–1 L min–1) air-oxygen-sevoflurane (1–3 MAC) anaesthesia; Group B included similar patients who received high flow (6 L min–1) anaesthesia. Non-cancer patients receiving low flow anaesthesia served as controls. Blood was sampled for serum creatinine, BUN, cistatin C, and electrolytes (Na+, K+, Cl–, Ca2+, P3+, Mg2+) before anaesthesia, and one, three and five days after.

Results
There were no statistically significant differences between the groups.

Conclusions
The use of low flow sevoflurane anaesthesia is not associated with an increased risk of nephrotoxicity in those previously exposed to nephrotoxic chemotherapeutic agents.

keywords:

anaesthesia, methods, low flow; anaesthetics, volatile, sevoflurane; chemotherapy, complications, nephrotoxicity

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.